Search

  • HOME
  • Search
Original Articles
13877
Clinical Outcomes of Topical Bromfenac Combined with Intravitreal Aflibercept Injection for Exudative Age-related Macular Degeneration
Mi Sun Kwon, Jin Young Kim, Yu Min Kim et al.
J Korean Ophthalmol Soc. 2024;65(1):27-34.   Published online January 15, 2024
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
13796
Efficacy of Injection Interval Shortening in Neovascular Age-related Macular Degeneration with Limited Response to Bimonthly Aflibercept
Min Chul Kim, Jae Hui Kim
J Korean Ophthalmol Soc. 2023;64(8):700-708.   Published online August 15, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
13743
Course of Neovascular Age-related Macular Degeneration that Showed Limited Response to Both Ranibizumab and Aflibercept
Jeong Seop Yun, Chul Gu Kim, Jong Woo Kim, Jae Hui Kim
J Korean Ophthalmol Soc. 2023;64(4):313-322.   Published online April 15, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
13691
Haller Layer Thickness after Intravitreal Aflibercept Injection in Diabetic Macular Edema: 1 Month Change
Su Min Sung, Kyoo Won Lee, Hyun Gu Kang
J Korean Ophthalmol Soc. 2022;63(12):973-983.   Published online December 15, 2022
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Case Reports
13679
A Case of Nonarteritic Anterior Ischemic Optic Neuropathy after Intravitreal Aflibercept Injection
Sungjun Joo, Joo Yeon Lee, Sung Uk Baek
J Korean Ophthalmol Soc. 2022;63(10):888-893.   Published online October 14, 2022
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Original Articles
13627
Outcome of Aflibercept-Bevacizumab Alternate Dosing in Neovascular Age-related Macular Degeneration with Limited Response to Aflibercept
Daeun Shin, Jae Hui Kim
J Korean Ophthalmol Soc. 2022;63(6):526-534.   Published online June 15, 2022
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
13512
Association between Vortex Vein Engorgement and Treatment Outcomes of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy
Areum Jeong, Min Sagong
J Korean Ophthalmol Soc. 2021;62(10):1370-1380.   Published online October 15, 2021
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
13491
Limited Treatment Response during Follow-up after Switching to Aflibercept in Neovascular Age-related Macular Degeneration
Gon Soo Choe, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim
J Korean Ophthalmol Soc. 2021;62(9):1218-1226.   Published online September 15, 2021
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
13473
Proportion of and Reason for Bevacizumab Usage in the Treatment of Wet Age-related Macular Degeneration
Yi Sang Yoon, Won Tae Yoon, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim
J Korean Ophthalmol Soc. 2021;62(8):1076-1083.   Published online August 15, 2021
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
13455
Comparison of Intravitreal Bevacizumab and Aflibercept Injections for Central Serous Chorioretinopathy
Min Soo Park, Seung Joon Lee
J Korean Ophthalmol Soc. 2021;62(7):957-962.   Published online July 15, 2021
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Budget Impact Analysis of Anti-vascular Endothelial Growth Factor in Patients with Diabetic Macular Edema.
Jangmi Yang, Sang Jin Shin, Jae Kyung Suh et al.
J Korean Ophthalmol Soc. 2019;60(7):667-675.   Published online July 15, 2019
PDFPDF    
Use of Anti-vascular Endothelial Growth Factors for Diabetic Retnopathy: National Health Insurance Claims Data.
Songhee Cho, Sang Jin Shin, Jae Kyung Suh et al.
J Korean Ophthalmol Soc. 2019;60(7):661-666.   Published online July 15, 2019
PDFPDF    
Analysis of Intraocular Pressure Elevation after Intravitreal Injection of Ranibizumab and Aflibercept.
Tae Kyu Moon, Jun Young Ha, Mi Sun Sung, Sang Woo Park
J Korean Ophthalmol Soc. 2019;60(4):362-368.   Published online April 15, 2019
PDFPDF    
Meta-analysis of Intravitreal Injection of Anti-vascular Endothelial Growth Factors for Diabetic Macular Edema.
Hajin Tchoe, Sang Jin Shin, Jae Kyung Suh et al.
J Korean Ophthalmol Soc. 2019;60(2):144-151.   Published online February 15, 2019
PDFPDF    
Clinical Changes after Switching from Ranibizumab/Aflibercept to Bevacizumab in Exudative Age-related Macular Degeneration.
In Ho Lee, Jae Jung Lee, Han Jo Kwon, Sung Who Park, Ji Eun Lee
J Korean Ophthalmol Soc. 2019;60(1):40-46.   Published online January 15, 2019
PDFPDF    

Journal of
the Korean
Ophthalmological
Society

Print ISSN: 0378-6471
Online ISSN: 2092-9374



ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next